Molecular Biomarker in Prostate Cancer: The Role of CpG Island Hypermethylation-Reference-Cited by-同舟云学术

Molecular Biomarker in Prostate Cancer: The Role of CpG Island Hypermethylation

Published:2004-12 Issue:6 Volume:46 Page:698-708
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Bastian Patrick J.,Yegnasubramanian Srinivasan,Palapattu Ganesh S.,Rogers Craig G.,Lin Xiaohui,De Marzo Angelo M.,Nelson William G.

Publisher

Elsevier BV

Subject

Urology

Reference131 articles.

1. Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy?;Soh;J Urol,1997

2. Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis;Lerner;J Urol,1996

3. The influence of finasteride on the development of prostate cancer;Thompson;N Engl J Med,2003

4. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: an autopsy study of 249 cases;Sakr;In Vivo,1994

5. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter;Thompson;N Engl J Med,2004

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostatic adenocarcinoma: molecular underpinnings and treatment-related options;Urologic Oncology: Seminars and Original Investigations;2024-07

2. Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review;Cancers;2024-01-25

3. Epigenomics, Transcriptomics, and Translational Control in Prostate Cancer;Prostate Cancer;2024

4. Methylation status of various gene loci in localized prostate cancer: Novel biomarkers for diagnostics and biochemical recurrence;Urologic Oncology: Seminars and Original Investigations;2023-07

5. DNA hypomethylation mediates immune response in pan-cancer;Epigenetics;2023-03-22